Skip to content

Latest

Gilead closes deal to acquire Pharmasset

Gilead Sciences Inc. has completed its acquisition of Pharmasset Inc., a clinical-stage pharmaceutical firm. Gilead said late Tuesday that its subsidiary, Royal Merger Sub II Inc., has finalized the transaction to buy Pharmasset for $137 per share in cash, or about $11.2 billion.

Kraft plans U.S. sales revamp, layoffs

Kraft Foods Inc. plans to realign its U.S. sales organization and lay off about 1,600 employees as it readies for a spin-off of its grocery business, splitting the food manufacturing giant into two public companies.

Bank praised by NCPA for nixing mandatory mail order

The National Community Pharmacists Association has applauded Regions Bank for rescinding its policy requiring employees to fill prescription drugs for chronic conditions via mail order pharmacies. NCPA said Tuesday that the bank’s new policy had been scheduled to become effective Jan.

GE, Bionime partner on blood glucose meter

GE Healthcare has entered into a global licensing pact with medical testing product specialist Bionime Corp. to provide new GE-branded solutions for the diabetes market. The GE100 Blood Glucose Monitoring System is the lead-off product in the GE-Bionime partnership. The General Electric Co.

Novo Nordisk, cooking star team on diabetes campaign

Novo Nordisk has partnered with celebrity cooks Paula Deen and her sons Bobby and Jamie Deen to launch "Diabetes in a New Light," a national effort to help adults find simple ways to manage type 2 diabetes. Celebrity cook Paula Deen with her sons Jamie (left) and Bobby. The diabetes care company

FDA finishes work on drug user-fee programs

The Food and Drug Administration has completed recommendations for three user-fee programs that commissioner Margaret Hamburg said will expedite the introduction of generic drugs and biosimilars to the market.

Q&A: Wasson sheds light on Express Scripts dispute

Despite an 11th-hour attempt, Walgreen Co. was unable to come to contract renewal terms with Express Scripts Inc. and the new year began without a deal in place, putting the drug chain out of the pharmacy benefit manager’s network.